Rigel Pharmaceuticals (NASDAQ:RIGL) reported its Q4 earnings results on Tuesday, March 1, 2022 at 04:01 PM.
Here’s what investors need to know about the announcement.
Earnings
Rigel Pharmaceuticals beat estimated earnings by 15.38%, reporting an EPS of $-0.11 versus an estimate of $-0.13.
Revenue was up $1.96 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.02 which was followed by a 2.52% drop in the share price the next day.
Here’s a look at Rigel Pharmaceuticals’s past performance:
| Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|
| EPS Estimate | -0.10 | -0.11 | -0.11 | |
| EPS Actual | -0.12 | -0.08 | 0.22 | -0.11 |
| Revenue Estimate | 23.56M | 20.37M | 31.05M | 18.10M |
| Revenue Actual | 21.54M | 26.27M | 81.02M | 18.45M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
